What Happens When You Stop Ozempic or Mounjaro? (2026 Guide)
Complete Guide & Evidence (2026)
Complete guide to stopping GLP-1 medications. Weight regain risks, how to taper off safely, and maintaining results after Ozempic or Mounjaro.
The Reality of Stopping GLP-1s
The hard truth: Studies show that most people regain 2/3 of their lost weight within 1 year of stopping semaglutide or tirzepatide. This isn't a failure—it's biology.
GLP-1 medications work by reducing hunger hormones and slowing gastric emptying. When you stop, these effects disappear within 2-3 weeks, and your appetite returns to baseline.
However, with proper planning and lifestyle changes established while on the medication, you can improve your odds of maintaining weight loss.
Should You Taper Off?
Cold turkey vs. tapering: There's no medical requirement to taper GLP-1 medications. Unlike some drugs, stopping abruptly doesn't cause withdrawal symptoms.
However, some doctors recommend tapering (e.g., going from 1mg → 0.5mg → 0.25mg over 4-6 weeks) to give your body time to adjust to returning hunger signals. This may reduce the shock of sudden appetite increase.
Guide FAQs
Complete guide to stopping GLP-1 medications. Weight regain risks, how to taper off safely, and maintaining results after Ozempic or Mounjaro.
Yes. Shotlee supports tracking Stopping GLP-1 doses, side effects, and health metrics. It is free to use.
Track Your Stopping GLP-1 Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Stopping GLP-1
Grim Effects of Stopping GLP-1s Like Ozempic, Study Finds
New research paints a stark picture: stopping GLP-1 drugs like Ozempic can rapidly reverse cardiovascular benefits, with risks spiking 8% after just six months. Published in BMJ Medicine, the study tracked over 333,000 adults and warns of 'metabolic whiplash.' Patients face weight regain, inflammation resurgence, and lasting scars from interruptions.
4 min read
Grim Effects of Stopping GLP-1s Like Ozempic, Study Reveals
New research paints a grim picture: stopping GLP-1 drugs like Ozempic can rapidly reverse cardiovascular benefits, with risks spiking 8% after just six months. A Washington University study of over 333,000 patients highlights the 'metabolic whiplash' of discontinuation. Understand the findings and why adherence matters.
5 min read
Stopping GLP-1 Drugs May Raise Heart Disease Risk, Study Finds
Popular GLP-1 drugs like semaglutide and tirzepatide offer heart health benefits for type 2 diabetes patients, but stopping them may reverse these gains. A Washington University study of over 333,000 veterans revealed up to 22% higher risk of heart attacks and strokes after discontinuation. Continuous use provides up to 18% risk reduction—here's what it means for long-term treatment.
5 min read